Interesting take on Valeant offer for Cephalon et alhttp://www.businessspectator.com.au/bs.nsf/Article/Pharma-Pharmaceuticals-Cephalon-drugs-ChemGenex-pd20110401-FH4X7?OpenDocument&src=kgb